Skip to main content

Search form

You are here

Kevin Dennis Hill, MD

Associate Professor of Pediatrics
Associate of the Duke Initiative for Science & Society
Member in the Duke Clinical Research Institute
Campus mail: DUMC Box 3090, Durham, NC 27710
Phone: (919) 668-8305
Email address: kevin.hill@duke.edu

Clinical research including outcomes, drug and device trials, short and long term safety and efficacy of interventions and hemodynamic effects of interventions.

Education and Training

  • Interventional Fellowship, Pediatrics, Vanderbilt University, 2008 - 2009
  • Pediatric Cardiology Fellowship, Pediatrics, Vanderbilt University, 2005 - 2008
  • Pediatric Residency, Pediatrics, Wake Forest University, 2002 - 2005
  • M.D., Wake Forest University, 2002

Selected Grants and Awards

Publications

King, Caitlin E., Elizabeth J. Thompson, Henry P. Foote, Kanecia O. Zimmerman, Kevin D. Hill, Reid Chamberlain, and Christoph P. Hornik. “An evidence-based review of the use of vasoactive and inotropic medications in post-operative paediatric patients after cardiac surgery with cardiopulmonary bypass from 2000 to 2020.” Cardiol Young 30, no. 12 (December 2020): 1757–71. https://doi.org/10.1017/S1047951120004151.

Full Text

Mayer, John E., Kevin Hill, Jeffrey P. Jacobs, David M. Overman, and S Ram Kumar. “The Society of Thoracic Surgeons Congenital Heart Surgery Database: 2020 Update on Outcomes and Research.” Ann Thorac Surg 110, no. 6 (December 2020): 1809–18. https://doi.org/10.1016/j.athoracsur.2020.10.004.

Full Text

Pasquali, Sara K., Dylan Thibault, Sean M. O’Brien, Jeffrey P. Jacobs, J William Gaynor, Jennifer C. Romano, Michael Gaies, et al. “National Variation in Congenital Heart Surgery Outcomes.” Circulation 142, no. 14 (October 6, 2020): 1351–60. https://doi.org/10.1161/CIRCULATIONAHA.120.046962.

Full Text

Manlhiot, Cedric, Jane W. Newburger, Tisiana Low, Nagib Dahdah, Andrew S. Mackie, Geetha Raghuveer, Therese M. Giglia, et al. “Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial.” In Can J Cardiol, 36:1598–1607, 2020. https://doi.org/10.1016/j.cjca.2020.01.016.

Full Text

Hill, Kevin D., Anil R. Maharaj, Jennifer S. Li, Elizabeth Thompson, Piers C. A. Barker, and Christoph P. Hornik. “A Randomized, Controlled Pharmacokinetic and Pharmacodynamics Trial of Ambrisentan After Fontan Surgery.” Pediatr Crit Care Med 21, no. 9 (September 2020): e795–803. https://doi.org/10.1097/PCC.0000000000002410.

Full Text

Pasquali, Sara K., Karen Chiswell, Matt Hall, Dylan Thibault, Jennifer C. Romano, J William Gaynor, David M. Shahian, et al. “Estimating Resource Utilization in Congenital Heart Surgery.” Ann Thorac Surg 110, no. 3 (September 2020): 962–68. https://doi.org/10.1016/j.athoracsur.2020.01.013.

Full Text

Fraser, Charles D., William Ravekes, Dylan Thibault, Brandi Scully, Karen Chiswell, Katherine Giuliano, Kevin D. Hill, et al. “Diaphragm Paralysis After Pediatric Cardiac Surgery: An STS Congenital Heart Surgery Database Study.” Ann Thorac Surg, August 5, 2020. https://doi.org/10.1016/j.athoracsur.2020.05.175.

Full Text

McCrindle, Brian W., Cedric Manlhiot, Jane W. Newburger, Ashraf S. Harahsheh, Therese M. Giglia, Frederic Dallaire, Kevin Friedman, et al. “Medium-Term Complications Associated With Coronary Artery Aneurysms After Kawasaki Disease: A Study From the International Kawasaki Disease Registry.” J Am Heart Assoc 9, no. 15 (August 4, 2020): e016440. https://doi.org/10.1161/JAHA.119.016440.

Full Text

Serfas, John D., Dylan Thibault, Nicholas D. Andersen, Karen Chiswell, Jeffrey P. Jacobs, Marshall L. Jacobs, Richard A. Krasuski, Andrew J. Lodge, Joseph W. Turek, and Kevin D. Hill. “The Evolving Surgical Burden of Fontan Failure: Insights from a Nationwide Surgical Database.” Ann Thorac Surg, August 4, 2020. https://doi.org/10.1016/j.athoracsur.2020.05.174.

Full Text

Hill, Kevin D., H Scott Baldwin, David P. Bichel, Alicia M. Ellis, Eric M. Graham, Christoph P. Hornik, Jeffrey P. Jacobs, et al. “Overcoming underpowering: Trial simulations and a global rank end point to optimize clinical trials in children with heart disease.” Am Heart J 226 (August 2020): 188–97. https://doi.org/10.1016/j.ahj.2020.05.011.

Full Text

Pages